The Duke Pediatric Blood and Marrow Transplantation (BMT) program offers family-centered, compassionate, expert treatment for children with recurrent cancers, rare genetic diseases, congenital immunodeficiency syndromes, hemoglobinopathies, and blood disorders.

It is a program of last resort: These children have a life expectancy of less than one year without a transplant.

With a current waiting list of 30 to 40 children, and a referral base that is worldwide, the Duke Pediatric Blood and Marrow Transplant Program is the largest children’s transplant program in the world, now transplanting some 100 children annually.

Duke PBMT has performed over 1,200 transplants since the program’s creation in 1990.

Today, over half of all the children treated at Duke since the program was established are surviving long-term and are considered cured of their underlying disease.